Ideas and Insight supporting all stages of Drug Discovery & Development

A recent survey of chemists, carried out by Elsevier’s Reaxys team, showed that only 13% identified a familiarity with machine learning (or similar technologies) as being important for future chemists. (more…)

At next week’s Bio IT World conference and expo (Boston, May 15-17), Elsevier will be giving four talks on the implications of AI and machine learning on life science research, a statistical analysis of concordance between animal toxicities and human adverse events, strategies for increasing data sharing and the latest technologies being used to integrate multiple data sources. (more…)

In the 21st century, we are facing a number of enormous global challenges. Simply producing enough food and clean water to nourish the planet’s growing population is one of the biggest difficulties. Meanwhile, we must also deal with the ravages of climate change and take on medical problems like antibiotic resistance. (more…)

Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. (more…)